author-photo

Mohammed Rassool

University of the Witwatersrand

19

Papers

633

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.

2021 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (12)
Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.

2021 AIDS
Show All
- Source
- Cite
- Save
Citations (0)
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial

2019 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (46)
Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial

2018 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (11)
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

2017 The Lancet HIV
Show All
- Source
- Cite
- Save
Citations (21)
Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial

2017
Show All
- Source
- Cite
- Save
Citations (2)
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial

2017 International Journal of Antimicrobial Agents
Show All
- Source
- Cite
- Save
Citations (14)
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.

2017 AIDS
Show All
- Source
- Cite
- Save
Citations (24)
Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial

2016 The Lancet HIV
Show All
- Source
- Cite
- Save
Citations (22)
Antiretroviral therapy in HIV‐1‐infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation

2016 Journal of Leukocyte Biology
Show All
- Source
- Cite
- Save
Citations (7)